Klusa VZ, Isajevs S, Svirina D, Pupure J, Beitnere U, Rumaks J, Svirskis S, Jansone B, Dzirkale Z, Muceniece R, Kalvinsh I, Vinters HV (2010) Neuroprotective properties of mildronate, a small molecule, in a rat model of Parkinson's disease
persistent gastrointestinal symptoms beyond 2 weeks after discontinuation
Finally, this treatment reduced the levels of the pro-inflammatory cytokines IL-1 and IL-33 while maintaining anti-inflammatory cytokine IL-10 levels, and maintained the levels of endogenous antioxidants in the colons of colitic mice (173)( Supplementary Table 1 )
Cryan JF, O'Riordan KJ, Cowan CSM, et al
CSU is associated with several disorders which either predispose to the condition or facilitate mast cell degranulation